Human Digestive Enzymes Create Different Lactoferrin Peptides Than Expected — Challenging Supplement Assumptions | Research

The takeaway

Human gastrointestinal digestion of bovine lactoferrin produces different bioactive peptide fragments than those found using non-human enzymes, with the key antimicrobial peptide lactoferricin notably absent.

No lactoferricin detected after human digestion
The most well-studied antimicrobial peptide from lactoferrin — lactoferricin f(17-41) — was completely absent after both in vitro and in vivo human digestion, despite being the basis for many supplement health claims.

What the researchers found

Human GI enzyme digestion of bovine lactoferrin generated peptide fragments that differed substantially from those produced by non-human enzymes. Critically, bovine lactoferricin f(17-41) — the most well-characterized antimicrobial fragment — was not detected after either in vitro or in vivo human digestion. Degradation was highly pH-dependent: high gastric enzyme concentration with rapid pH reduction to 2.5 caused complete degradation, while slower pH reduction or higher pH preserved more intact lactoferrin. Proteolytic cutting sites were located on the protein surface, mainly on the non-glycosylated half. A proline-hydrophobic motif was identified that restricted proteolytic processing.

Why it matters

Lactoferrin supplements are widely marketed for immune support and antimicrobial benefits, often citing research on lactoferricin and other bioactive fragments. But those fragments were identified using non-human enzymes. This study reveals that human digestion produces fundamentally different peptides, calling into question whether oral lactoferrin supplements actually deliver the specific bioactive peptides that have been studied. This has major implications for supplement efficacy claims.

How the study worked

Bovine lactoferrin was digested using actual human gastrointestinal juices in a two-step in vitro model mimicking stomach and duodenal conditions. Gastric pH was varied (slowly or rapidly reduced to 2.5 or 4.0) to simulate different food buffering capacities. Results were compared with in vivo digestion data from 2 human volunteers. Peptides were identified by mass spectrometry and compared to previously reported lactoferrin-derived peptide sequences.

What this study cannot tell us

Very small in vivo component (only 2 volunteers), limiting the ability to assess individual variation. The in vitro model, while using human GI juices, may still not perfectly replicate the complexity of in vivo digestion. The study focused on bovine lactoferrin; human lactoferrin digestion may differ. Peptide identification may have missed some low-abundance fragments. The functional significance of the newly identified peptides was not tested.

How to read the evidence

This is a well-designed in vitro digestion study using actual human GI juices, with limited in vivo validation (2 subjects). The mass spectrometry peptide identification is robust, but the very small in vivo component and lack of functional testing of the identified peptides are limitations.

When this study was published

Published in 2013, this study's findings remain highly relevant as lactoferrin supplements have grown significantly in popularity since. Its conclusions about human-specific digestion patterns are still underappreciated in the supplement industry.

The bigger picture

This study highlights a critical gap in bioactive peptide research: most peptide discovery work uses purified individual enzymes rather than the complex mixture of enzymes found in the actual human gut. As regulators like the European Food Safety Authority approve peptide-containing supplements, understanding what the human digestive system actually produces from these proteins becomes essential for honest health claims and effective product design.

Questions still open

Do the peptide fragments actually produced by human digestion of lactoferrin have antimicrobial or other bioactive properties?
Should lactoferrin supplement formulations be redesigned to protect specific bioactive peptides from premature degradation?
How much individual variation exists in lactoferrin digestion, and does this affect who benefits from supplementation?

Common questions

Does oral lactoferrin actually work as a supplement?

This study raises important questions. It found that human digestion breaks down lactoferrin into different peptide fragments than those typically studied in the lab. Notably, lactoferricin — the fragment most cited for antimicrobial benefits — was completely absent after human digestion. This doesn't mean lactoferrin has no benefits, but the specific benefits claimed based on lab-derived peptides may not apply when taken orally.

Why does it matter what enzymes are used to study lactoferrin digestion?

Your gut contains a complex mix of digestive enzymes that's quite different from the single purified enzymes typically used in lab studies. This study showed that human digestive juices produce fundamentally different peptide fragments from lactoferrin compared to animal or purified enzymes. Since health benefits depend on which specific peptides are produced, the choice of enzymes in research directly affects whether results are relevant to people actually taking the supplement.

Read the original research

Identification of lactoferrin peptides generated by digestion with human gastrointestinal enzymes.

Journal of dairy science, 96(1), 75-88

View on PubMed ↗Publisher’s paper ↗

Citation

Furlund, C B; Ulleberg, E K; Devold, T G; Flengsrud, R; Jacobsen, M; Sekse, C; Holm, H; Vegarud, G E. (2013). Identification of lactoferrin peptides generated by digestion with human gastrointestinal enzymes.. Journal of dairy science, 96(1), 75-88. https://doi.org/10.3168/jds.2012-5946